Lumen gets $16M for C. diff drug; Flashpoint’s seed round; Amplifier expands Series A
Plus, Tessellate BIO, led by former Big Pharma execs, comes out of stealth.
Lumen Bioscience gets $16M to advance C. diff therapy: The Department of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
